ES2179206T3 - Derivados de 12h-dibenzo(d,g)(1,3)dioxocina. - Google Patents

Derivados de 12h-dibenzo(d,g)(1,3)dioxocina.

Info

Publication number
ES2179206T3
ES2179206T3 ES96930027T ES96930027T ES2179206T3 ES 2179206 T3 ES2179206 T3 ES 2179206T3 ES 96930027 T ES96930027 T ES 96930027T ES 96930027 T ES96930027 T ES 96930027T ES 2179206 T3 ES2179206 T3 ES 2179206T3
Authority
ES
Spain
Prior art keywords
rent
dioxocine
dibenzo
derivatives
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96930027T
Other languages
English (en)
Inventor
Rolf Hohlweg
Tine Krogh Joergensen
Knud Erik Andersen
Uffe Bang Olsen
Peter Madsen
Zendek Polivka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Application granted granted Critical
Publication of ES2179206T3 publication Critical patent/ES2179206T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Abstract

UN COMPUESTO DE FORMULA (I), EN DONDE R 1 Y R 2 INDEPENDIENTEMENTE SON HIDROGENO, HALOGENO, TRIFLUOROMETILO, HIDROXI, C 1 - 6 -ALQUIL O C 1 - 6 - ALCOXI; Y R 3 ES HIDROGENO O C 1 - 3 - ALQUIL; Y A ES C 1 - 3 ALQUILENO; E Y ES >CH - CH2 -, >C = CH -, >CH - O -, >C - N -, >N - CH 2 -, EN DONDE SOLO EL ATOMO SUBRAYADO PARTICIPA EN EL SISTEMA CICLICO, METODOS PARA SU PREPARADO, COMPOSICIONES QUE LOS CONTIENEN, Y SU USO EN EL TRATAMIENTO CLINICO DE PROCESOS DOLOROSOS, HIPERALGESICOS Y/O INFLAMATORIOS EN QUE LOS QUE LAS FIBRAS C DESEMPEÑAN UN PAPEL FISIOPATOLOGICO POR SU INDUCCION DE DOLOR NEUROGENICO O SECUNDARIO A INFLAMACION.
ES96930027T 1995-09-19 1996-09-12 Derivados de 12h-dibenzo(d,g)(1,3)dioxocina. Expired - Lifetime ES2179206T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK104195 1995-09-19
DK104095 1995-09-19

Publications (1)

Publication Number Publication Date
ES2179206T3 true ES2179206T3 (es) 2003-01-16

Family

ID=26065121

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96930027T Expired - Lifetime ES2179206T3 (es) 1995-09-19 1996-09-12 Derivados de 12h-dibenzo(d,g)(1,3)dioxocina.

Country Status (22)

Country Link
US (6) US5753678A (es)
EP (1) EP0851865B1 (es)
JP (1) JP3499569B2 (es)
KR (1) KR100437561B1 (es)
CN (1) CN1090629C (es)
AR (1) AR004513A1 (es)
AT (1) ATE220674T1 (es)
AU (1) AU700784B2 (es)
BR (1) BR9610524A (es)
CA (1) CA2231835A1 (es)
CZ (1) CZ70998A3 (es)
DE (1) DE69622415T2 (es)
ES (1) ES2179206T3 (es)
HU (1) HUP9900079A3 (es)
IL (1) IL123424A (es)
MX (1) MX9802126A (es)
NO (1) NO981216L (es)
PL (1) PL186708B1 (es)
PT (1) PT851865E (es)
RU (1) RU2178790C2 (es)
TW (1) TW406078B (es)
WO (1) WO1997011071A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5952352A (en) * 1995-04-07 1999-09-14 Novo Nordisk A/S Heterocyclic compounds
RU2188197C2 (ru) * 1996-10-04 2002-08-27 Ново Нордиск А/С 1,4-дизамещенные пиперазины, способ их получения, фармацевтическая композиция и способ лечения нейрогенного воспаления
US6040318A (en) * 1997-06-25 2000-03-21 Novo Nordisk A/S Tricycle substituted with azaheterocyclic carboxylic acids
TW200400816A (en) 2002-06-26 2004-01-16 Lilly Co Eli Tricyclic steroid hormone nuclear receptor modulators
HUE026904T2 (en) * 2003-04-24 2016-08-29 Incyte Holdings Corp Aza-spiroalkane derivatives as inhibitors of metalloproteases
WO2007143600A2 (en) * 2006-06-05 2007-12-13 Incyte Corporation Sheddase inhibitors combined with cd30-binding immunotherapeutics for the treatment of cd30 positive diseases

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU174126B (hu) * 1977-08-02 1979-11-28 Egyt Gyogyszervegyeszeti Gyar Sposob poluchenija novykh proizvodnykh dibenzo-kvadratnaja skobka-d,g-kvadratnaja skobka zakryta-kvadratnaja skobka-1,3,6-kvadratnaja skobka zakryta-dioksazocina
HU195491B (en) * 1985-12-20 1988-05-30 Egyt Gyogyszervegyeszeti Gyar Process for production of optically active 2-chlor-12-/3-/dimethil-amin/-2-methil-prophil/-12h-dibenzol /d,g/ /1,3,6/-diaxazocine and medical compositions containing such compounds
HU201318B (en) * 1987-12-31 1990-10-28 Egyt Gyogyszervegyeszeti Gyar Process for producing dioxazoline derivatives and pharmaceutical compositions comprising same
CN1074926A (zh) * 1992-01-29 1993-08-04 大连石油化工公司有机合成厂 混合原油破乳剂的制备方法

Also Published As

Publication number Publication date
JPH11506470A (ja) 1999-06-08
TW406078B (en) 2000-09-21
WO1997011071A1 (en) 1997-03-27
CA2231835A1 (en) 1997-03-27
US5917047A (en) 1999-06-29
CZ70998A3 (cs) 1998-08-12
NO981216D0 (no) 1998-03-18
AR004513A1 (es) 1998-12-16
RU2178790C2 (ru) 2002-01-27
CN1090629C (zh) 2002-09-11
MX9802126A (es) 1998-05-31
HUP9900079A2 (hu) 1999-10-28
IL123424A0 (en) 1998-09-24
AU700784B2 (en) 1999-01-14
CN1196729A (zh) 1998-10-21
US5912262A (en) 1999-06-15
US5972925A (en) 1999-10-26
AU6923496A (en) 1997-04-09
US5916901A (en) 1999-06-29
BR9610524A (pt) 1999-07-06
HUP9900079A3 (en) 2000-02-28
KR100437561B1 (ko) 2004-07-16
ATE220674T1 (de) 2002-08-15
DE69622415D1 (de) 2002-08-22
EP0851865A1 (en) 1998-07-08
NO981216L (no) 1998-03-18
PL325637A1 (en) 1998-08-03
US6017915A (en) 2000-01-25
US5753678A (en) 1998-05-19
PL186708B1 (pl) 2004-02-27
PT851865E (pt) 2002-11-29
KR19990063593A (ko) 1999-07-26
EP0851865B1 (en) 2002-07-17
DE69622415T2 (de) 2003-03-06
JP3499569B2 (ja) 2004-02-23
IL123424A (en) 2002-02-10

Similar Documents

Publication Publication Date Title
BR9907788A (pt) Agentes antiinflamatórios seletivos paraglicocorticóides
ATE42895T1 (de) Steroide als immunomodulierende mittel.
ES2038676T3 (es) Nuevos mejoradores de absorcion percutanea, composiciones que los contienen y metodo de uso.
BR0112160A (pt) Agentes antiinflamatórios seletivos para glicocorticóides
MX9301929A (es) Derivados de pirimidina y procedimientos para su preparacion.
DE69329240D1 (de) 17-ether und thioether von 4-aza-steroiden
KR960701051A (ko) 이미다조피리딘 및 이를 위장 질환의 치료에 사용하는 방법(imidazopyridines and their use in treating castrointestinal diseases)
ES2104090T3 (es) Nuevas 3',5'-di-t-butil-4'-hidroxi-flavonas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
PA8485601A1 (es) Azalidas de 13 miembros y su uso como agentes antibioticos.
BR9907847A (pt) Agentes anti-inflamatórios seletivos para glucocorticóides
PT93213A (pt) Processo para a preparacao de derivados de n-fenilbenzamida com accao anti-ulcerosa e anti-alergica e de composicoes farmaceuticas que os contem
MX9204637A (es) Nuevos derivados de pirazina y procedimiento para su preparacion.
ES2187738T3 (es) Derivados de flavonas, su procedimiento de preparacion y los compuestos farmaceuticos que las contienen.
ES2135769T3 (es) Derivados de isotiourea como inhibidores de no-sintasa.
ES2059534T3 (es) Nuevos derivados benzopiranos antihipertensivos.
ES2179206T3 (es) Derivados de 12h-dibenzo(d,g)(1,3)dioxocina.
MX9308006A (es) Derivados de 4-benzoilisoxazol, procedimiento para su preparcion y composicion herbicida que los comprende.
EP0186023A3 (en) Biliary acid derivatives, process for their preparation and pharmaceutical compositions containing them
IS4367A (is) CCK eða gastrín temprandi 5-heterósýklísk-1,5-bensódíazepín
ES546372A0 (es) Procedimiento para preparar nuevos esteroides sustituidos en posicion 10.
ATE200223T1 (de) Sampangin-derivate zur verwendung als antimykotische und antimykobakterielle wirkstoffe
FI814112L (fi) Deka- undeka- dodeka- och tridekapeptider som har thymusaktivitet
BR9611276A (pt) Composto formulação farmacêutica processo para tratamento ou profilaxia de doenças ou condições de seres humanos e uso de um composto
MX9203039A (es) Derivados de isoindolina y composicion farmaceutica que los contiene.
BR9906975A (pt) Composto, uso do mesmo, composição farmacêutica, e, processo para estimular a liberação do hormÈnio do crescimento pela pituitária de um mamìfero